» Articles » PMID: 24040059

Lack of Association Between Hsa-miR-149 Rs2292832 Polymorphism and Cancer Risk: a Meta-analysis of 12 Studies

Overview
Journal PLoS One
Date 2013 Sep 17
PMID 24040059
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: MicroRNAs (miRNAs) participate in various cellular processes such as cell growth, differentiation, cell death and play an important role in a variety of diseases, especially in cancer. Recently, a number of studies have investigated the association between single nucleotide polymorphisms (SNPs) on the hsa-miR-149 rs2292832 and susceptibility to cancer; however, the results remain inconclusive.

Methodology/principal Findings: We carried out a meta-analysis of 12 studies including 5937 cases and 6081 controls from PubMed to assess the association between the hsa-miR-149 rs2292832 and cancer risk by pooled odds ratios (ORs) and 95% confidence intervals (CIs). However, our results showed that genotype distribution of the hsa-miR-149 rs2292832 was not associated with cancer risk in all genetic models. Subgroup analysis by cancer type, ethnicity or study design showed no significant association either.

Conclusion: Results of this meta-analysis suggest that the hsa-miR-149 rs2292832 polymorphism is not associated with cancer risk in spite of the potentially protective role of C allele in hepatocellular carcinoma and male gastric cancer.

Citing Articles

Assessment of the relationship between miR-499C/T (rs3746444) polymorphism and lung carcinoma in Iranian population; a case-control study.

Torabi M, Khafaei M, Jahanbin B, Sadeghi M Afr Health Sci. 2024; 23(3):301-307.

PMID: 38357128 PMC: 10862644. DOI: 10.4314/ahs.v23i3.36.


Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis.

Zhou C, Wang P, Tu M, Huang Y, Xiong F, Wu Y Cancer Manag Res. 2020; 12:3771-3782.

PMID: 32547213 PMC: 7248804. DOI: 10.2147/CMAR.S246311.


MiR-149-5p regulates cisplatin chemosensitivity, cell growth, and metastasis of oral squamous cell carcinoma cells by targeting TGFβ2.

Luo K, He J, Yu D, Acil Y Int J Clin Exp Pathol. 2020; 12(10):3728-3739.

PMID: 31933761 PMC: 6949764.


Regulation and functions of MicroRNA-149 in human cancers.

Zhi Y, Zhou H, Mubalake A, Chen Y, Zhang B, Zhang K Cell Prolif. 2018; 51(5):e12465.

PMID: 29999552 PMC: 6528861. DOI: 10.1111/cpr.12465.


MiR-149 Compromises the Reactions of Liver Cells to Fatty Acid via its Polymorphism and Increases Non-Alcoholic Fatty Liver Disease (NAFLD) Risk by Targeting Methylene Tetrahydrofolate Reductase (MTHFR).

An X, Yang Z, An Z Med Sci Monit. 2017; 23:2299-2307.

PMID: 28507283 PMC: 5443364. DOI: 10.12659/msm.901377.


References
1.
Yang Q, Jie Z, Ye S, Li Z, Han Z, Wu J . Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene. 2012; 33(2):193-202. DOI: 10.1038/onc.2012.569. View

2.
Chen K, Song F, Calin G, Wei Q, Hao X, Zhang W . Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis. 2008; 29(7):1306-11. DOI: 10.1093/carcin/bgn116. View

3.
Hu Z, Liang J, Wang Z, Tian T, Zhou X, Chen J . Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat. 2008; 30(1):79-84. DOI: 10.1002/humu.20837. View

4.
Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, Simi L . Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med. 2011; 49(12):2073-80. DOI: 10.1515/CCLM.2011.708. View

5.
Egger M, Davey Smith G, Schneider M, Minder C . Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315(7109):629-34. PMC: 2127453. DOI: 10.1136/bmj.315.7109.629. View